IBDEI14K ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18061,1,4,0)
 ;;=4^E10.41
 ;;^UTILITY(U,$J,358.3,18061,2)
 ;;=^5002605
 ;;^UTILITY(U,$J,358.3,18062,0)
 ;;=E10.42^^88^908^11
 ;;^UTILITY(U,$J,358.3,18062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18062,1,3,0)
 ;;=3^DM Type 1 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,18062,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,18062,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,18063,0)
 ;;=E10.43^^88^908^2
 ;;^UTILITY(U,$J,358.3,18063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18063,1,3,0)
 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,18063,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,18063,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,18064,0)
 ;;=E10.44^^88^908^1
 ;;^UTILITY(U,$J,358.3,18064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18064,1,3,0)
 ;;=3^DM Type 1 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,18064,1,4,0)
 ;;=4^E10.44
 ;;^UTILITY(U,$J,358.3,18064,2)
 ;;=^5002608
 ;;^UTILITY(U,$J,358.3,18065,0)
 ;;=E10.49^^88^908^25
 ;;^UTILITY(U,$J,358.3,18065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18065,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,18065,1,4,0)
 ;;=4^E10.49
 ;;^UTILITY(U,$J,358.3,18065,2)
 ;;=^5002609
 ;;^UTILITY(U,$J,358.3,18066,0)
 ;;=E10.59^^88^908^22
 ;;^UTILITY(U,$J,358.3,18066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18066,1,3,0)
 ;;=3^DM Type 1 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,18066,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,18066,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,18067,0)
 ;;=E10.610^^88^908^9
 ;;^UTILITY(U,$J,358.3,18067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18067,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,18067,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,18067,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,18068,0)
 ;;=E10.618^^88^908^23
 ;;^UTILITY(U,$J,358.3,18068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18068,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,18068,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,18068,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,18069,0)
 ;;=E10.630^^88^908^30
 ;;^UTILITY(U,$J,358.3,18069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18069,1,3,0)
 ;;=3^DM Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,18069,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,18069,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,18070,0)
 ;;=E10.638^^88^908^27
 ;;^UTILITY(U,$J,358.3,18070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18070,1,3,0)
 ;;=3^DM Type 1 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,18070,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,18070,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,18071,0)
 ;;=E10.641^^88^908^15
 ;;^UTILITY(U,$J,358.3,18071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18071,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,18071,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,18071,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,18072,0)
 ;;=E10.649^^88^908^16
 ;;^UTILITY(U,$J,358.3,18072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18072,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,18072,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,18072,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,18073,0)
 ;;=E10.65^^88^908^14
 ;;^UTILITY(U,$J,358.3,18073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18073,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,18073,1,4,0)
 ;;=4^E10.65
